Rob Maloney: How Our Camp Brings Relief to Children with Bleeding Disorders and Their Families
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”We talk a lot about what our camp does for kids.
And we should. It matters on a lot of levels.
It gives them courage, belonging, freedom and so much more.
It’s a chance to stop feeling like the only one.
But one of the most honest things I’ve heard about camp came from a parent.
She didn’t give me a polished speech. She just said, in her own way, that camp gave her a week to breathe.
Parents of children with bleeding disorders do not really clock out.
They are always aware. Always watching. Always running scenarios in the background.
- What if he falls?
- What if she starts bleeding?
- What if the school doesn’t know what to do?
- What if we’re out of town?
- What if I miss something?
Even in good seasons, that kind of vigilance takes a toll.
So when a family trusts our camp and they know the doctors are there, the nurses are there, the counselors understand, and their child is safe, something rare happens.
The child gets to be a child. And the parent gets to exhale.
That is not a small thing.
In rare disease care, we often focus on the patient, and rightly so.
But families carry this too.
Parents carry it in their bodies, in their schedules, in their sleep, in their relationships and the way they move through the world.
Sometimes one of the most meaningful things an organization can offer is not just another meeting.
Sometimes it’s a week where everyone can breathe a little easier.
We can’t wait for camp!”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 20:44Mary Cushman: Starting ISTH 2026 With Women’s Thrombosis and Hemostasis Health
-
Jul 12, 2026, 20:43Elif Güler Kazanci: Honored to Attend ISTH 2026
-
Jul 12, 2026, 20:41Anna Waterhouse: Exciting First Day at the ISTH 2026
-
Jul 12, 2026, 20:39Ghadir Alkarithi: Exploring the Latest Advances at ISTH 2026
-
Jul 12, 2026, 20:21Rainer Kaiser: How T Cells Boost Myeloid Effector Functions in Endocarditis
-
Jul 12, 2026, 17:04Marc Carrier: EPCAT III Trial at ISTH 2026 Supports Aspirin Alone for VTE Prevention After Arthroplasty
-
Jul 12, 2026, 16:15Louise St. Germain Bannon: Global Collaboration Is Key to Turning Scientific Innovation Into Better Care
-
Jul 12, 2026, 16:10Marc Carrier: Major Scientific Highlight Confirms the Safety of the YEARS Algorithm at ISTH 2026
-
Jul 12, 2026, 16:01Joseph R. Shaw: Sharing New Insights into Antithrombotic Therapy and Thrombin Generation at ISTH 2026